Ganowa da Jiyya don COVID-19 (Gwajin gwaji 8) ta Hukumar Lafiya ta Kasa ta PRC
Hatsarin thromboembolism ya fi girma a cikin mawuyacin hali ko marasa lafiya, ……, Anticoagulants ya kamata a yi amfani da su ta hanyar kariya. Idan kuma ana fama da cutar ƙwaƙwalwa, to ya kamata a gudanar da maganin ƙin jini bisa ga jagororin da suka dace.

2. — CELL SARS-CoV-2 Kamuwa da cuta ya dogara da Sulfate na Heparan na Cellular da ACE2, Heparin da ƙananan ƙwayoyin cuta ba tare da hana ƙwayar SARSCoV-2 ɗaurewa da kamuwa da cuta ba.

Maganin da kawai ake amfani da shi a wannan yanki shine maganin rigakafin ƙananan ƙwayar heparin (LMWH), wanda yakamata a yi la'akari da shi a cikin duk marasa lafiya da ke cikin asibiti tare da sabon cututtukan huhu (ciki har da marasa lafiya masu tsanani) ba tare da takaddama ba.
ISTH jagora na wucin gadi akan fitarwa da gudanar da coagulopathy a cikin COVID-19

A cikin marasa lafiya (manya da matasa) wadanda aka kwantar da su a asibiti tare da COVID-19, yi amfani da maganin hana yaduwar magani, kamar su heparin mai nauyin kwayar halitta (kamar su enoxaparin), bisa ga ka'idojin cikin gida da na duniya, don hana yaduwar cuta, yayin da ba a hana ta ba.

5.Duk marasa lafiya masu cutar COVID-19 mai tsanani da mahimmanci, maras ƙarfi ko ƙananan haɗarin zubar jini, kuma ba a ba da shawarar yin amfani da kwayoyi don hana VTE, kuma ƙananan ƙwayar ƙwayar heparin ita ce zaɓi na farko; saboda tsananin ƙarancin koda, ana bada shawara ga heparin mara kariya.
Ga marasa lafiya marasa lafiya da gama gari, idan akwai haɗari ko matsakaici na VTE, ana ba da shawarar rigakafin ƙwayoyi bayan an kawar da rikice-rikicen, kuma ƙananan ƙwayar heparin shine farkon zaɓi.

Rigakafin da Kula da Cutar Tashin Hanya da ke Haɗuwa da Cutar Coronavirus 2019 Kamuwa da cuta: Bayanin Tattaunawa kafin Sharuɗɗa